Evidence map›Paper›PMID 29603093›Full record

ArticleMolecular neurobiology2018

Oxaliplatin Modulates the Characteristics of Voltage-Gated Calcium Channels and Action Potentials in Small Dorsal Root Ganglion Neurons of Rats.

Linda-Isabell Schmitt, Markus Leo, Christoph Kleinschnitz, Tim Hagenacker

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Oxaliplatin-induced peripheral neuropathy: from pathogenesis to treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Linda-Isabell SchmittDepartment of Neurology, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Markus LeoDepartment of Neurology, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Christoph KleinschnitzDepartment of Neurology, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
Tim HagenackerDepartment of Neurology, University of Duisburg-Essen, Hufelandstrasse 55, D-45122, Essen, Germany. tim.hagenacker@uk-essen.de.ORCID http://orcid.org/0000-0002-3631-3450

Funding

Corona Foundation S199/10061/2016Deutsche Forschungsgemeinschaft HA 6202/4-1
6 · The paper itself

Abstract

Oxaliplatin is important for treating colorectal cancer. Although oxaliplatin is highly effective, it has severe side effects, of which neurotoxicity in dorsal root ganglion (DRG) neurons is one of the most common. The key mechanisms of this neurotoxicity are still controversial. However, disturbances of calcium homeostasis in DRG neurons have been suggested to mediate oxaliplatin neurotoxicity. By using whole-cell patch-clamp and current-clamp techniques, as well as immunocytochemical staining, we examined the influence of short- and long-term exposure to oxaliplatin on voltage-gated calcium channels (VGCC) and different VGCC subtypes in small DRG neurons of rats in vitro. Exposure to oxaliplatin reduced VGCC currents (I

Indexed as

Action PotentialsAnimalsApoptosisCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channel BlockersCalcium Channels, N-TypeCaspase 3FemaleGanglia, SpinalIon Channel GatingMaleNeuronsOxaliplatinRats, Sprague-DawleyCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channel BlockersCalcium Channels, N-TypeCaspase 3OxaliplatinChemotherapyIon channelsNeuropathic painNeurotoxicityPolyneuropathySensory neurons

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.